Listen
In this episode, host Alyssa Watson, DVM, welcomes Margret Lenfest, VMD, DACVSMR, CVA, to discuss a recent Clinician’s Brief article, “Canine Therapeutic Joint Injections.” Dr. Lenfest dives into the upside, downside, inside, and outside of injecting joints. She also details the most commonly used products for intra-articular therapy: triamcinolone, hyaluronic acid, and platelet-rich plasma.
Watch
Key Takeaways
Intra-articular therapy can address the problem directly where it is and spare the need for other systemic medications like NSAIDs.
Some common injectates include corticosteroids (e.g., triamcinolone), hyaluronic acid, and platelet-rich plasma either used alone or in combination.
Early intervention tends to go better with the goal being several months of benefit following intra-articular injection.
Only inject 1-2 joints initially until you have experience with that specific patient’s response, then you can adjust moving forward.
Infected joints, immune-mediated joint disease, and cancer are some of the contraindications along with ensuring the skin is suitable for sterile needle passage and the patient can tolerate sedation.
Resource:
Contact:
Where To Find Us:
Website: CliniciansBrief.com/Podcasts
YouTube: Youtube.com/@clinicians_brief
Facebook: Facebook.com/CliniciansBrief
LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
Instagram: @Clinicians.Brief
The Team:
Alyssa Watson, DVM - Host
Alexis Ussery - Producer & Multimedia Specialist